What is Rigel Pharmaceuticals's revenue?

Rigel Pharmaceuticals (RIGL) generated $299.8M in revenue over the trailing twelve months, up 47.6% year over year.

Is Rigel Pharmaceuticals profitable?

Rigel Pharmaceuticals reported $364.2M in net income over the trailing twelve months, a 121.5% net margin.

What are Rigel Pharmaceuticals's profit margins?

Gross margin is 93.4% and operating margin is 41.6%, with a 121.5% net margin.

What is Rigel Pharmaceuticals's earnings per share?

Rigel Pharmaceuticals's diluted EPS over the trailing twelve months is $19.28.

Where does Rigel Pharmaceuticals's income statement data come from?

Every line is extracted from Rigel Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Rigel Pharmaceuticals RIGL Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Total revenue	$299.77M+1.9%	$294.28M+4.3%	$282.08M+5.3%	$267.92M+31.9%	$203.08M+13.3%
Total cost of revenue	$19.82M+1.0%	$19.62M+0.9%	$19.46M-14.4%	$22.73M+8.1%	$21.03M+12.8%
Gross profit	$279.95M+1.9%	$274.66M+4.6%	$262.62M+7.1%	$245.19M+34.7%	$182.05M+13.3%
Gross margin	93.4%+0.1pp	93.3%+0.2pp	93.1%+1.6pp	91.5%+1.9pp	89.6%0.0pp
Research and development	$36.54M+9.7%	$33.3M+17.9%	$28.24M+4.3%	$27.07M+5.0%	$25.79M+10.3%
Selling, general and administrative	$118.84M+2.5%	$115.9M+0.4%	$115.43M+1.7%	$113.54M+1.1%	$112.33M-0.6%
Total costs & expenses	$175.19M+3.8%	$168.82M+3.5%	$163.13M-0.1%	$163.33M+2.6%	$159.15M+2.6%
Operating income	$124.58M-0.7%	$125.47M+5.5%	$118.95M+13.7%	$104.59M+138%	$43.93M+81.6%
Operating margin	41.6%-1.1pp	42.6%+0.5pp	42.2%+3.1pp	39%+17.4pp	21.6%+8.1pp
Interest expense	$6.9M-5.7%	$7.32M-3.4%	$7.58M-2.1%	$7.74M-2.0%	$7.9M-0.3%
Income before income taxes	$121.97M+0.1%	$121.83M+6.6%	$114.34M+15.3%	$99.14M+160%	$38.12M+108%
Income tax expense	-$242.26M+1.2%	-$245.2M-23,791%	$1.04M-21.3%	$1.32M+39.0%	$946K+7.4%
Net income	$364.23M-0.8%	$367.02M+224%	$113.3M+15.8%	$97.82M+163%	$37.18M+113%
Net margin	121.5%-3.2pp	124.7%+84.6pp	40.2%+3.7pp	36.5%+18.2pp	18.3%+8.6pp
Diluted earnings per share	$19.28-1.0%	$19.47+215%	$6.18+14.0%	$5.42+161%	$2.08+112%
EBITDA	$126.99M-0.7%	$127.88M+5.4%	$121.37M+13.4%	$107.01M+131%	$46.36M+75.5%
EBITDA margin	42.4%-1.1pp	43.5%+0.4pp	43%+3.1pp	39.9%+17.1pp	22.8%+8.1pp
EBIT	$124.58M-0.7%	$125.47M+5.5%	$118.95M+13.7%	$104.59M+138%	$43.93M+81.6%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Rigel Pharmaceuticals.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Rigel Pharmaceuticals's revenue?: Rigel Pharmaceuticals (RIGL) generated $299.8M in revenue over the trailing twelve months, up 47.6% year over year.
Is Rigel Pharmaceuticals profitable?: Rigel Pharmaceuticals reported $364.2M in net income over the trailing twelve months, a 121.5% net margin.
What are Rigel Pharmaceuticals's profit margins?: Gross margin is 93.4% and operating margin is 41.6%, with a 121.5% net margin.
What is Rigel Pharmaceuticals's earnings per share?: Rigel Pharmaceuticals's diluted EPS over the trailing twelve months is $19.28.
Where does Rigel Pharmaceuticals's income statement data come from?: Every line is extracted from Rigel Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.